Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-22 · accession 0001628280-24-049297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-26 | 2024-11-22 | AMRX | Kiely John | Dir | M - OptEx | $4.76 | +28.5K | 284.2K | +11% | +$135.7K |
| D | 2024-11-26 | 2024-11-22 | AMRX | Kiely John | Dir | S - Sale+OE | $8.38 | -17.1K | 267.2K | -6% | -$142.9K |
| D | 2024-11-26 | 2024-11-22 | AMRX | Kiely John | Dir | M - OptEx | $0.00 | -28.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-22 | M | A | 28,506 | $4.76 | 284,233 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-11-22 | S | D | 17,058 | $8.38 | 267,175 | D | — | — | (F1) Reflects shares sold to cover the exercise price arising in connection with the exercise of the stock options. |
| 3 | Derivative | Stock Option | 2024-11-22 | M | D | 28,506 | $0.00 | 0 | D | $4.76 · — to 2029-12-14 | 28,506 Class A Common Stock | (F2) The option is vested and currently exercisable. |